T 0293/22 (Fab fragments/SUTRO BIOPHARMA) of 10.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T029322.20230310
- Date of decision
- 10 March 2023
- Case number
- T 0293/22
- Petition for review of
- -
- Application number
- 14788445.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Selection of Fab fragments using ribosomal display technology
- Applicant name
- Sutro Biopharma, Inc.
- Opponent name
- GeneFrontier Corporation
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 111(1)Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 012(2)
- Keywords
- Grounds for opposition - added subject-matter (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.